Related Experiment Video
Updated: Mar 27, 2026

High-throughput Detection of Respiratory Pathogens in Animal Specimens by Nanoscale PCR
Published on: November 28, 2016
Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia
Naomi J Gadsby1, Clark D Russell1,2, Martin P McHugh1
1Medical Microbiology, Department of Laboratory Medicine, Royal Infirmary of Edinburgh.
Comprehensive molecular testing significantly improves pathogen detection in community-acquired pneumonia (CAP) patients, especially those previously treated with antimicrobials. This method enables pathogen-directed therapy and antimicrobial de-escalation.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Respiratory Medicine
Background:
- Community-acquired pneumonia (CAP) diagnosis is often missed microbiologically, hindering targeted antimicrobial treatment.
- This study investigated advanced molecular testing for multiple bacteria and viruses in hospitalized CAP patients.
Purpose of the Study:
- To evaluate the efficacy of comprehensive molecular testing in diagnosing CAP.
- To assess the potential for antimicrobial de-escalation based on molecular test results.
Main Methods:
- 323 adult CAP patients from UK hospitals were analyzed.
- Lower respiratory tract (LRT) specimens were tested using multiplex real-time PCR for 26 pathogens, with bacterial quantification for 8.
- Culture-based methods were used as a comparator.
Main Results:
- Molecular testing detected pathogens in 87% of CAP cases, versus 39% with culture.
- Common pathogens included Haemophilus influenzae and Streptococcus pneumoniae; viruses were found in 30%, often with bacteria.
- Molecular testing identified pathogens in 78% of antimicrobial-exposed patients, compared to 32% by culture, potentially enabling de-escalation in 77% of cases.
Conclusions:
- Comprehensive molecular testing substantially increases pathogen detection in CAP using a single LRT specimen.
- This approach is particularly beneficial for antimicrobial-exposed patients, facilitating early de-escalation to pathogen-directed therapy.
Related Concept Videos
Pneumonia III: Complications and Assessment
Atypical Pneumonia
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Common Respiratory Disorders
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

